skin cancer Flashcards

1
Q

2 types of non-melanoma skin cancer?

A

basal cell cancer (BCC)

Squamous cell cancer (SCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common NMSC?

A

BCCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4 risk factors for NMSC?

A

UV radiation
photochemotherapy (PUVA)
HPV
immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 features of BCC?

A

slow growing
locally invasive
rarely metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

presentation of nodular BCC - 3 features?

A

pearly rolled edge

telangiectasia

central ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

telangiectasia?

A

widened venules (tiny blood vessels) cause threadlike red lines/patterns on the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe appearance of superficial BCC?

A

usually red,
sometimes raised,
can be crusty,
~1cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe appearance of pigmented BCC?

A

looks like black spot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe appearance of morphoeic BCC?

A

looks like white burn/scar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

gold standard treatment of BCCs?

A

excision - ellipse with a rim of unaffected skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1 adv and 1 disadv to gold standard treatment of BCC?

A

adv - curative if fully excised

disadv - scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 other treatments of BCCs?

A

curettage

imiquimod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Mohs surgery?

A

surgicaltechnique where thin layers of cancer-containing skin are progressively removed and examined until only cancer-free tissue remains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

6 indications for Mohs?

A
size 
site
subtype
poor clinical margin definition 
recurrent 
perineurial/perivascular involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

indications for vismodegib?

A

local advanced BCC not suitable for surgery/radiotherapy
OR
metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

action of vismodegib?

A

inhibits abnormal signalling in hedgehog pathway

17
Q

side effects of vismodegib?

A
hair loss 
weight loss 
altered taste 
muscle spasms
nausea 
fatigue
18
Q

derivation of squamous cell carcinoma?

A

keratinising squamous cells

19
Q

where are SCCs usually found?

A

sun exposed sites

20
Q

4 features of SCC?

A

faster growth
tender
crusty
ulceration

21
Q

treatment for SCC?

A

excision +/- radiotherapy

22
Q

when should follow-up be carried out with SCCs?

A

with high risk patients

23
Q

describe high risk patients for SCCs?

A

immunosuppressed
>20mm diameter
>4mm depth
site of eyelid, ear, lip, nose

24
Q

what is keratoacanthoma?

A

variant of SCC which originates in hair follicles in sun damaged skin

25
treatment for keratoacanthoma?
surgical excision
26
name 4 risk factors for melanoma?
UV radiation fair skin / red hair / blue eyes history of sunburn as a child / inability to tan familial melanoma / melanoma susceptibility genes
27
ABCDE for melanoma?
``` asymmetry border colour diameter evolution ```
28
7 point checklist?
change in size change in shape change in colour diameter >5mm inflammation oozing/bleeding itch/altered sensation
29
1 advantage of dermoscopy?
improved clinical accuracy compared to unaided eye
30
4 subtypes of melanoma?
lentigo maligna melanoma nodular melanoma acral lentiginous melanoma superficial spreading malignant melanoma
31
rarer subtype of melanoma?
ocular melanoma
32
treatments of melanoma?
surgical excision - wide local excision sentinel lymph node biopsy immunotherapy
33
rarer treatments for melanoma?
chemotherapy | radiotherapy
34
breslow thickness?
the distance between the upper layer of the epidermis and the deepest point of tumour
35
name 4 adjuvant therapies used for melanoma?
ipilimumab pembrolizumab nivolumab vemurafenib with dabrafenib
36
action of ipilimumab?
inhibits CTLA-4
37
action of pembrolizumab?
targets PD-1 receptor on tumour
38
metastatic melanoma - treatment?
adjuvent therapy